138 related articles for article (PubMed ID: 35747984)
1. Development and Validation of a Hypoxia-related Prognostic Model for Ovarian Cancer.
Xie L; Pan M; Zhang Z; Jiang X; Chen Y; Liu G; Chen Y; Zeng Y; Guan J; Lu R; Zeng L
Recent Pat Anticancer Drug Discov; 2022; 18(2):161-173. PubMed ID: 35747984
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer.
Zhang W; Liu T; Jiang L; Chen J; Li Q; Wang J
Front Genet; 2022; 13():1001239. PubMed ID: 36425071
[No Abstract] [Full Text] [Related]
3. Novel immune-related gene signature for risk stratification and prognosis prediction in ovarian cancer.
Fei H; Han X; Wang Y; Li S
J Ovarian Res; 2023 Oct; 16(1):205. PubMed ID: 37858138
[TBL] [Abstract][Full Text] [Related]
4. A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer.
Xu X; Wu Y; Jia G; Zhu Q; Li D; Xie K
J Ovarian Res; 2023 Jan; 16(1):5. PubMed ID: 36611197
[TBL] [Abstract][Full Text] [Related]
5. Identification of copper metabolism-related subtypes and establishment of the prognostic model in ovarian cancer.
Zhao S; Zhang X; Gao F; Chi H; Zhang J; Xia Z; Cheng C; Liu J
Front Endocrinol (Lausanne); 2023; 14():1145797. PubMed ID: 36950684
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
Song Y; Qu H
BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analyses of mitophagy-related genes and mitophagy-related lncRNAs for patients with ovarian cancer.
Zheng J; Jiang S; Lin X; Wang H; Liu L; Cai X; Sun Y
BMC Womens Health; 2024 Jan; 24(1):37. PubMed ID: 38218807
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of a 9-gene signature for the prognosis of ovarian cancer by integrated bioinformatical analysis.
Chen S; Yang M; Yang H; Tang Q; Gu C; Wei W
Ann Transl Med; 2022 Oct; 10(19):1059. PubMed ID: 36330389
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer.
Yu J; Liu TT; Liang LL; Liu J; Cai HQ; Zeng J; Wang TT; Li J; Xiu L; Li N; Wu LY
Cancer Cell Int; 2021 Jul; 21(1):353. PubMed ID: 34229669
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis for the immune related biomarkers of platinum-based chemotherapy in ovarian cancer.
Liu J; Liu Y; Yang C; Liu J; Hao J
Transl Oncol; 2023 Nov; 37():101762. PubMed ID: 37619523
[TBL] [Abstract][Full Text] [Related]
11. Identifying a hypoxia related score to predict the prognosis of bladder cancer: a study with The Cancer Genome Atlas (TCGA) database.
Zhang Z; Li Q; Li A; Wang F; Li Z; Meng Y; Zhang Q
Transl Androl Urol; 2021 Dec; 10(12):4353-4364. PubMed ID: 35070817
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of the Diagnostic Characteristic Genes of Ovarian Cancer by Bioinformatics and Machine Learning.
Liu J; Liu L; Antwi PA; Luo Y; Liang F
Front Genet; 2022; 13():858466. PubMed ID: 35719392
[No Abstract] [Full Text] [Related]
13. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
14. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
15. Identifying the Role of Oxidative Stress-Related Genes as Prognostic Biomarkers and Predicting the Response of Immunotherapy and Chemotherapy in Ovarian Cancer.
Liu Q; Yang X; Yin Y; Zhang H; Yin F; Guo P; Zhang X; Sun C; Li S; Han Y; Yang Z
Oxid Med Cell Longev; 2022; 2022():6575534. PubMed ID: 36561981
[TBL] [Abstract][Full Text] [Related]
16. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
17. Development of a five-gene signature as a novel prognostic marker in ovarian cancer.
Wang R; Ye XH; Zhao XL; Liu JL; Zhang CY
Neoplasma; 2019 May; 66(3):343-349. PubMed ID: 30569721
[TBL] [Abstract][Full Text] [Related]
18. Establishment and Validation of a Tumor Microenvironment Prognostic Model for Predicting Bladder Cancer Survival Status Based on Integrated Bioinformatics Analyses.
Chen Q; Yin G; He X; Jiang T; Zhou H; Wu Y; Li Y
Evid Based Complement Alternat Med; 2022; 2022():4351005. PubMed ID: 36225190
[TBL] [Abstract][Full Text] [Related]
19. A Novel Glycosyltransferase-Related Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer.
Wang L
Int J Gen Med; 2021; 14():10337-10350. PubMed ID: 34992448
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
Yue C; Ma H; Zhou Y
PeerJ; 2019; 7():e8128. PubMed ID: 31803536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
